Compare GRFS & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | MGY |
|---|---|---|
| Founded | 1940 | 2017 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.8B |
| IPO Year | N/A | 2017 |
| Metric | GRFS | MGY |
|---|---|---|
| Price | $7.64 | $25.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $10.15 | ★ $30.36 |
| AVG Volume (30 Days) | 647.2K | ★ 5.6M |
| Earning Date | 07-28-2022 | 05-06-2026 |
| Dividend Yield | 1.80% | ★ 2.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $1,311,845,000.00 |
| Revenue This Year | $4.49 | $14.65 |
| Revenue Next Year | $6.42 | $1.99 |
| P/E Ratio | ★ $18.67 | $107.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.96 | $21.07 |
| 52 Week High | $11.14 | $32.76 |
| Indicator | GRFS | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 42.11 |
| Support Level | $7.64 | $25.24 |
| Resistance Level | $7.73 | $27.86 |
| Average True Range (ATR) | 0.16 | 0.86 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 68.62 | 37.81 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).